Concepedia

Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial

Christian Taucher, Rajeka Lazarus, Hanna Dellago, Petronela Weisova, Irena Corbic Ramljak, Katrin Dubischar, Anders Lilja, Susanne Eder-Lingelbach, Romana Hochreiter, Juan Carlos Jaramillo,

Journal of Infection · 2023 · 14 citations · 30 references

DOIFull text

Open access

Concepts

References

30

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan, José Mateus, Yu Kato et al. · Science · 2021 · 3K citations · Full text

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

New England Journal of Medicine · 2022 · 2.2K citations · Full text

A global database of COVID-19 vaccinations

Edouard Mathieu, Hannah Ritchie, Esteban Ortiz-Ospina et al. · Nature Human Behaviour · 2021 · 2.1K citations · Full text